| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 07/12/2007 | WO2007077934A1 Anti-periostin antibody and pharmaceutical composition for preventing or treating periostin-related disease containing the same |
| 07/12/2007 | WO2007077510A2 Muscarinic receptor antagonists |
| 07/12/2007 | WO2007076572A1 A method of treatment |
| 07/12/2007 | WO2007029078A3 Succinimide and glutarimide derivatives as adrenergic receptor antagonists |
| 07/12/2007 | WO2007010552A3 N- terminal peg conjugate of erythropoietin |
| 07/12/2007 | US20070161709 Amorphous tamsulosin hydrochloride |
| 07/12/2007 | US20070161707 Pharmaceutical uses for alpha2delta ligands |
| 07/12/2007 | US20070161706 Pharmaceutical uses for alpha2delta ligands |
| 07/12/2007 | US20070161681 Ether derivatives useful as inhibitors of pde4 isozymes |
| 07/12/2007 | US20070161647 QUINOLINE-4-CARBOXAMIDE DERIVATIVES AS NK-3 and NK-2 RECEPTOR ANTAGONISTS |
| 07/12/2007 | US20070161607 immunosuppressive treatment of autoimmune disorders or inflammatory diseases; [Tris-(4-fluoro-phenyl)-methyl]-phosphonic acid dimethyl ester; Gardos channel antagonists |
| 07/12/2007 | US20070161549 Glycosylation-deficient hepatocyte growth factor |
| 07/12/2007 | US20070160668 Prolonged release bioadhesive therapeutic systems |
| 07/12/2007 | US20070160614 Human TIMP-1 antibodies |
| 07/12/2007 | US20070160603 Antibodies Against Tumor Necrosis Factor Delta (APRIL) |
| 07/12/2007 | US20070160594 Method of Diagnosing and Treating Cartilaginous Disorders |
| 07/12/2007 | CA2635849A1 An antibody against periosin, and a pharmaceutical composition comprising it for preventing or treating a disease in which periosin is involved |
| 07/12/2007 | CA2635335A1 Muscarinic receptor antagonists |
| 07/12/2007 | CA2633013A1 A method of treatment |
| 07/11/2007 | EP1806338A1 Process for producing 2-amino-2-[2-[4-(3-benzyloxyphenylthio)-2-chlorophenyl[ethyl]-1,3-propanediol hydrochloride or hydrate thereof and intermediate for the same |
| 07/11/2007 | EP1806143A2 Baff receptor (BCMA), an immunoregulatory agent |
| 07/11/2007 | EP1806137A1 Therapeutic agent for glomerular disease |
| 07/11/2007 | EP1806136A1 Medicinal composition for prevention of transition to operative treatment for prostatic hypertrophy |
| 07/11/2007 | EP1804810A1 Methods using glycosaminoglycans for the treatment of kidney disease |
| 07/11/2007 | EP1804778A1 Use of a beta-3 agonist for treating complaints of the prostate and the lower urogenital tract |
| 07/11/2007 | EP1248784B1 Condensed azepines as vasopressin agonists |
| 07/11/2007 | EP1204414B1 Use of morphinan derivates as medicines |
| 07/11/2007 | EP1175398B1 Indoline derivatives as progesterone antagonists |
| 07/11/2007 | EP1140907B1 Triazole compounds with dopamine-d3-receptor affinity |
| 07/11/2007 | CN1997621A Crystalline forms of (-)-(1r,2r)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)-phenol hydrochloride |
| 07/11/2007 | CN1995064A Long-lasting recombinant human red blood cell growth factor fusion protein and method |
| 07/11/2007 | CN1995039A Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 07/11/2007 | CN1994456A Medicament for treating acute pyelonephritis |
| 07/11/2007 | CN1994433A Kidney-tonifying health product and preparation method thereof |
| 07/11/2007 | CN1994337A Total flavone extract of maniod eibish, its preparation and application |
| 07/11/2007 | CN1994329A Enzyme hydrolysis preparation of liquid turtle shell glue and antler glue and its application in preparation of 'Gui Lu Er Xian Gao' |
| 07/11/2007 | CN1994286A Application of total curcumin in preparation of medicine for preventing and postponing chronic kidney function failure |
| 07/11/2007 | CN1994159A Kidney-strengthening mind-refreshing tobacco liquid for electronic atomized cigarette |
| 07/11/2007 | CN1325644C Muteins of human neutrophil gelatinase-associated lipocalin and related proteins |
| 07/11/2007 | CN1325637C Ependymal neural stem cells and method for their isolation |
| 07/11/2007 | CN1325507C 17alpha-alkyl-17beta-oxy-estratrienes, uses thereof and pharmaceutical preparations |
| 07/11/2007 | CN1325491C Novel crystals |
| 07/11/2007 | CN1325488C Heterocyclic derivatives |
| 07/11/2007 | CN1325479C Pyrimidine compounds |
| 07/11/2007 | CN1325094C Medicine for treating uaemia and insufficiency of kidney-yang and kidney exhaustion and its preparing method |
| 07/11/2007 | CN1325071C Antiphlogistic medicine |
| 07/11/2007 | CN1325070C Chinese traditional medicine Tripterygium wilfordii and improving technique for attenuation and synergy of its extract |
| 07/11/2007 | CN1325069C Preparation method of rape myricyl powder effective portion group |
| 07/11/2007 | CN1325054C Cyclic dextrin inclusion compound of mintpress hydrochloride and its preparing method |
| 07/10/2007 | US7241869 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 07/10/2007 | US7241782 Modifications are prepared by subjecting an alkaline solution of torasemide to a rapid acidification with inorganic or organic acids at 0 to 35 degrees C. |
| 07/10/2007 | US7241777 Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors |
| 07/10/2007 | US7241762 Administering racemic reboxetine or a salt thereof for inhibition of norepinephrine reuptake |
| 07/10/2007 | US7241758 Aromatic compounds containing urea or thiourea groups are useful for terating cytokine mediated diseases |
| 07/10/2007 | US7241738 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 07/10/2007 | US7241733 Mammalian EPO mimetic CH1 deleted mimetibodies, compositions, methods and uses |
| 07/10/2007 | US7241619 Identification of genes encoding enzymes (Thraustochytrium aureum Delta 5-desaturase, Saprolegnia diclina Delta 5-desaturase, Saprolegnia diclina Delta 6-desaturase)involved in synthesis of polyunsaturated fatty acids |
| 07/10/2007 | CA2421910C Xanthine phosphodiesterase v inhibitors |
| 07/10/2007 | CA2396814C Novel 1,3-dihydro-2h-indol-2-one derivatives, preparation method and pharmaceutical compositions containing them |
| 07/10/2007 | CA2128706C Polyunsaturated fatty acid based drugs, in particular docosahexaenoic acid, as platelet aggregation inhibitors and against essential fatty acid deficiencies of the brain |
| 07/05/2007 | WO2007076159A2 Pure darifenacin hydrobromide substantially free of oxidized darifenacin and salts thereof and processes for the preparation thereof |
| 07/05/2007 | WO2007074916A1 3,4-dihydrobenzoxazine compound and inhibitor of vanilloid receptor type 1 (vr1) activity |
| 07/05/2007 | WO2007074291A2 Incontinence treatment methods |
| 07/05/2007 | WO2007074073A1 Use of alkoxylates of monovalent and polyvalent alcohols or derivatives thereof as an antibiotic substitute in the feeding of animals |
| 07/05/2007 | WO2007073855A1 Use of adenosine a1 receptor agonists for the protection of renal cells against toxic effects caused by aminoglycosides during treatment of infectious diseases |
| 07/05/2007 | US20070157326 Ee3-protein family and corresponding dna sequence |
| 07/05/2007 | US20070155989 Trifluoroacetate blocking of alanine amino group, friedel crafts reaction with methoxybenzene, reduction of carbonyl group, chlorosulphonation and deprotection; claimed tamsulosin intermediates; simplification |
| 07/05/2007 | US20070155838 New Method for Treating Urinary Disorders |
| 07/05/2007 | US20070155801 Advanced glycation end-product intermediaries and post-amadori inhibition |
| 07/05/2007 | US20070155788 inhibitors of cGMP PDE, especially Type 5; erectile dysfunction and sexual disorders; 6-Bromo-N-[(3-chloro-methoxyphenyl)methyl]-2-(2-pyridinyl)-4-quinolinamine |
| 07/05/2007 | US20070155775 inhibitors of cGMP PDE, especially Type 5; erectile dysfunction and sexual disorders; 6-Bromo-N-[(3-chloro-methoxyphenyl)methyl]-2-(2-pyridinyl)-4-quinolinamine |
| 07/05/2007 | US20070155756 Treatment of chemokine mediated diseases |
| 07/05/2007 | US20070155734 Oxime and/or hydrazone containing nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 07/05/2007 | US20070155732 Aryl or Heteroaryl Fused Imidazole Compounds as Anti-Inflammatory and Analgesic Agents |
| 07/05/2007 | US20070155713 Nitrogen-containing heterocyclic compounds and use thereof |
| 07/05/2007 | US20070154912 87 Human Secreted Proteins |
| 07/05/2007 | US20070154428 Thiazole derivative |
| 07/05/2007 | US20070154392 treating a cancerous disease which includes characterizing a disease by an overexpression of one or more somatostatin receptors, exposing such somatostatin receptors to a pharmaceutical formulation containing a somatostatin analogue which binds to the one or more somatostatin receptor |
| 07/05/2007 | CA2634542A1 Incontinence treatment methods |
| 07/05/2007 | CA2632508A1 3,4-dihydrobenzoxazine compound and inhibitor of vanilloid receptor type 1 (vr1) activity |
| 07/05/2007 | CA2625858A1 Pure darifenacin hydrobromide substantially free of oxidized darifenacin and salts thereof and processes for the preparation thereof |
| 07/04/2007 | EP1803730A1 Albumin fusion proteins |
| 07/04/2007 | EP1802600A1 Substituted 4-benzyloxy-phenylmethylamide derivatives as cold menthol receptor-1 (cmr-1) antagonits for the treatment of urological disorders |
| 07/04/2007 | EP1802309A2 Method and composition for supplementation of nutritional deficiencies in renal patients |
| 07/04/2007 | EP1644343B1 5-substituted quinazolinone derivatives |
| 07/04/2007 | EP1397128B1 Kappa opoid agonist for the treatment of irritable bladder |
| 07/04/2007 | EP1054594B1 Inotropic and diuretic effects of exendin and glp-1 |
| 07/04/2007 | CN1993467A Gene related with prostate disease and encoding polypeptides and its application |
| 07/04/2007 | CN1990486A N-glycyl-pyrrolidine-2-nitrile and its use as DDP-IV enzyme inhibitor |
| 07/04/2007 | CN1990474A 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia |
| 07/04/2007 | CN1990473A Tri-substituted 1H-imidazoles compounds, preparation method and pharmaceutical composition and pharmacy use thereof |
| 07/04/2007 | CN1990469A Pyrrolidines as dipeptidyl peptidase inhibitors |
| 07/04/2007 | CN1990468A Pyrrolidines as dipeptidyl peptidase inhibitors |
| 07/04/2007 | CN1990457A 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 07/04/2007 | CN1990025A Use of nicandra physaloides in preparation of drug for the treatment of chronic prostatitis and prostatic hyperplasia |
| 07/04/2007 | CN1990022A Traditional Chinese medicine composition, its preparation and quality controlling means |
| 07/04/2007 | CN1989995A Medicine for treating benign prostate hyperplasia and its preparation process |
| 07/04/2007 | CN1989972A Finasteroid oral preparation and method for preparing same |
| 07/04/2007 | CN1989965A Palmatine colon positoning agent and its preparation and usage |
| 07/04/2007 | CN1989855A Cordyceps sinensis cigarette and process for manufacturing same |